Nichi-Iko Pharmaceutical Co Ltd (4541):企業の財務・戦略的SWOT分析

◆英語タイトル:Nichi-Iko Pharmaceutical Co Ltd (4541) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14851
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahistine mesilate tablets, calcium gluconate hydrate powder, candesartan cilexetil tablets and diltiazem hydrochloride table, among others. Its products are used for treatments of circulatory, digestive, respiratory, central and peripheral nervous systems. Nichi-Iko offers manufacturing, sales, distribution, export, import and related activities for various types of pharmaceuticals. The company operates in Sapporo, Sendai, Kanto, Tokai-Hokuriku, Osaka, Hiroshima, Fukuoka, and others. Nichi-Iko is headquartered in Toyama, Japan.

Nichi-Iko Pharmaceutical Co Ltd Key Recent Developments

Jul 09,2018: Nichi-Iko Pharmaceutical: Business alliance with Sunward Pharmaceutical
Apr 17,2018: Nichi-Iko Pharmaceutical: Announcement of completion of new production facility by Aprogen Biologics
Apr 17,2018: Announcement of completion of new production facility by Aprogen Biologics
Feb 07,2018: Nichi-Iko Pharmaceutical Reports Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2018

This comprehensive SWOT profile of Nichi-Iko Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nichi-Iko Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Nichi-Iko Pharmaceutical Co Ltd – Key Information
Nichi-Iko Pharmaceutical Co Ltd – Overview
Nichi-Iko Pharmaceutical Co Ltd – Key Employees
Nichi-Iko Pharmaceutical Co Ltd – Key Employee Biographies
Nichi-Iko Pharmaceutical Co Ltd – Key Operational Heads
Nichi-Iko Pharmaceutical Co Ltd – Major Products and Services
Nichi-Iko Pharmaceutical Co Ltd – History
Nichi-Iko Pharmaceutical Co Ltd – Company Statement
Nichi-Iko Pharmaceutical Co Ltd – Locations And Subsidiaries
Nichi-Iko Pharmaceutical Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Nichi-Iko Pharmaceutical Co Ltd – Business Description
Nichi-Iko Pharmaceutical Co Ltd – Corporate Strategy
Nichi-Iko Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Nichi-Iko Pharmaceutical Co Ltd – Strengths
Nichi-Iko Pharmaceutical Co Ltd – Weaknesses
Nichi-Iko Pharmaceutical Co Ltd – Opportunities
Nichi-Iko Pharmaceutical Co Ltd – Threats
Nichi-Iko Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Nichi-Iko Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Nichi-Iko Pharmaceutical Co Ltd, Key Information
Nichi-Iko Pharmaceutical Co Ltd, Key Ratios
Nichi-Iko Pharmaceutical Co Ltd, Share Data
Nichi-Iko Pharmaceutical Co Ltd, Major Products and Services
Nichi-Iko Pharmaceutical Co Ltd, History
Nichi-Iko Pharmaceutical Co Ltd, Key Employees
Nichi-Iko Pharmaceutical Co Ltd, Key Employee Biographies
Nichi-Iko Pharmaceutical Co Ltd, Key Operational Heads
Nichi-Iko Pharmaceutical Co Ltd, Other Locations
Nichi-Iko Pharmaceutical Co Ltd, Subsidiaries
Nichi-Iko Pharmaceutical Co Ltd, Key Manufacturing facilities
Nichi-Iko Pharmaceutical Co Ltd, Key Competitors
Nichi-Iko Pharmaceutical Co Ltd, SWOT Analysis
Nichi-Iko Pharmaceutical Co Ltd, Ratios based on current share price
Nichi-Iko Pharmaceutical Co Ltd, Annual Ratios
Nichi-Iko Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Nichi-Iko Pharmaceutical Co Ltd, Performance Chart
Nichi-Iko Pharmaceutical Co Ltd, Ratio Charts

★海外企業調査レポート[Nichi-Iko Pharmaceutical Co Ltd (4541):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JPMorgan Chase & Co.:企業の戦略・SWOT・財務情報
    JPMorgan Chase & Co. - Strategy, SWOT and Corporate Finance Report Summary JPMorgan Chase & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務情報
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Global Partners LP (GLP)-石油・ガス分野:企業M&A・提携分析
    Summary Global Partners LP (Global Partners) is a midstream logistics and marketing company. It carries out purchasing, selling and logistics of transporting domestic and Canadian crude oil and other products by rail across its virtual pipeline from the mid-continent region of the US and Canada to t …
  • Sypris Solutions, Inc.:企業の戦略・SWOT・財務情報
    Sypris Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sypris Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TETRA Technologies Inc (TTI):企業の財務・戦略的SWOT分析
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology cen …
  • Penn Virginia Corporation (PVAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Penn Virginia Corp (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company’s operations consist primarily of drilling unconventional horizontal development wells and operating producing well …
  • HESTA Super Fund:企業の戦略的SWOT分析
    HESTA Super Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Holland Colours NV (HOLCO):企業の財務・戦略的SWOT分析
    Holland Colours NV (HOLCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SKY Network Television Limited (SKT):企業の財務・戦略的SWOT分析
    SKY Network Television Limited (SKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Hindustan Construction Co. Ltd (HCC):企業の財務・戦略的SWOT分析
    Hindustan Construction Co. Ltd (HCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia Biosciences) is an agricultural and clean technology company that develops and commercializes agricultural products. The company's products exhibit traits include drought tolerance, stacked traits, herbicide tolerance, water use efficiency, nitrogen use effic …
  • N Brown Group plc:企業の戦略・SWOT・財務情報
    N Brown Group plc - Strategy, SWOT and Corporate Finance Report Summary N Brown Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Entravision Communications Corp (EVC):企業の財務・戦略的SWOT分析
    Entravision Communications Corp (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Xiwang Sugar Holdings Co Limited:企業の戦略・SWOT・財務情報
    Xiwang Sugar Holdings Co Limited - Strategy, SWOT and Corporate Finance Report Summary Xiwang Sugar Holdings Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • HepQuant Llc:企業の製品パイプライン分析2018
    Summary Hepquant LLC (Hepquant) is a medical device company that offers diagnostic products. The company develops and markets patented and patent-pending technology for assessing liver function of patients with chronic liver disease. It offers investigational combination drug and diagnostic devices. …
  • Thermo Fisher Scientific Inc.:企業のM&A・事業提携・投資動向
    Thermo Fisher Scientific Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Thermo Fisher Scientific Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • FGL Sports Ltd.:企業の戦略・SWOT・財務情報
    FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report Summary FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pyxant Labs Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that provides good laboratory practice (GLP) bioanalytical chemistry support and contract research services. The laboratory offers services such as picogram-level bioanalytical method development, analytical and bioanalytical support for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆